| Bioactivity | TLR7 agonist 9 (compound 10) is an aonist of TLR7. TLR7 agonist 9 can be used for research of cancer and infectious disease[1]. |
| Name | TLR7 agonist 9 |
| CAS | 2389988-38-7 |
| Formula | C14H17N5O7 |
| Molar Mass | 367.31 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [2]. Webber Stephen E, et al. TLR7 agonists for treatment of cancer and infectious disease. World Intellectual Property Organization, WO2019226977 A1. 2019-11-28. |
TLR7 agonist 9
CAS: 2389988-38-7 F: C14H17N5O7 W: 367.31
TLR7 agonist 9 (compound 10) is an aonist of TLR7. TLR7 agonist 9 can be used for research of cancer and infectious dise
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.